

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cellular potassium ion homeostasis (GO:0030007) | 8.03222958 |
| 2 | response to pheromone (GO:0019236) | 7.95554127 |
| 3 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 7.91707397 |
| 4 | fructose metabolic process (GO:0006000) | 7.20119687 |
| 5 | positive regulation of synapse maturation (GO:0090129) | 7.10819923 |
| 6 | cerebellar Purkinje cell layer development (GO:0021680) | 7.05842207 |
| 7 | cerebellar granule cell differentiation (GO:0021707) | 6.96449857 |
| 8 | protein heterotetramerization (GO:0051290) | 6.82490821 |
| 9 | metanephric tubule development (GO:0072170) | 6.69480910 |
| 10 | metanephric nephron tubule development (GO:0072234) | 6.69480910 |
| 11 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 6.34622333 |
| 12 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 6.32436118 |
| 13 | metanephric nephron epithelium development (GO:0072243) | 6.21441653 |
| 14 | collecting duct development (GO:0072044) | 6.12220470 |
| 15 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 5.94078448 |
| 16 | neurofilament cytoskeleton organization (GO:0060052) | 5.92619660 |
| 17 | multicellular organismal movement (GO:0050879) | 5.91193320 |
| 18 | musculoskeletal movement (GO:0050881) | 5.91193320 |
| 19 | detection of light stimulus involved in visual perception (GO:0050908) | 5.82862339 |
| 20 | detection of light stimulus involved in sensory perception (GO:0050962) | 5.82862339 |
| 21 | potassium ion homeostasis (GO:0055075) | 5.80788282 |
| 22 | synaptic vesicle exocytosis (GO:0016079) | 5.75989456 |
| 23 | cerebellar Purkinje cell differentiation (GO:0021702) | 5.71429257 |
| 24 | sodium ion export (GO:0071436) | 5.70626039 |
| 25 | metanephric epithelium development (GO:0072207) | 5.69867403 |
| 26 | positive regulation of muscle hypertrophy (GO:0014742) | 5.63430250 |
| 27 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 5.63430250 |
| 28 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 5.61967244 |
| 29 | regulation of synapse maturation (GO:0090128) | 5.60483837 |
| 30 | aggressive behavior (GO:0002118) | 5.47906792 |
| 31 | inositol phosphate-mediated signaling (GO:0048016) | 5.37605513 |
| 32 | retinal rod cell development (GO:0046548) | 5.19634601 |
| 33 | cell differentiation in hindbrain (GO:0021533) | 5.12421232 |
| 34 | neurotransmitter-gated ion channel clustering (GO:0072578) | 5.11929059 |
| 35 | glutamate receptor signaling pathway (GO:0007215) | 5.09632176 |
| 36 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.09041839 |
| 37 | retina layer formation (GO:0010842) | 5.08809336 |
| 38 | relaxation of smooth muscle (GO:0044557) | 5.05740090 |
| 39 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 4.92860369 |
| 40 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.92043513 |
| 41 | negative regulation of norepinephrine secretion (GO:0010700) | 4.86669166 |
| 42 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.86590985 |
| 43 | locomotory exploration behavior (GO:0035641) | 4.74177890 |
| 44 | behavioral response to nicotine (GO:0035095) | 4.70958975 |
| 45 | synaptic vesicle endocytosis (GO:0048488) | 4.67932669 |
| 46 | negative regulation of heart rate (GO:0010459) | 4.66072331 |
| 47 | synaptic vesicle maturation (GO:0016188) | 4.64186771 |
| 48 | positive regulation of glomerulus development (GO:0090193) | 4.59693701 |
| 49 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 4.55985469 |
| 50 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.52926482 |
| 51 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.46179675 |
| 52 | layer formation in cerebral cortex (GO:0021819) | 4.44246439 |
| 53 | vocalization behavior (GO:0071625) | 4.38456727 |
| 54 | regulation of voltage-gated calcium channel activity (GO:1901385) | 4.28997612 |
| 55 | protein localization to synapse (GO:0035418) | 4.28760370 |
| 56 | neurotransmitter secretion (GO:0007269) | 4.22152591 |
| 57 | prepulse inhibition (GO:0060134) | 4.07771057 |
| 58 | positive regulation of amino acid transport (GO:0051957) | 4.02161322 |
| 59 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 4.00936665 |
| 60 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 3.97426323 |
| 61 | urinary tract smooth muscle contraction (GO:0014848) | 3.92827367 |
| 62 | chemosensory behavior (GO:0007635) | 3.92448601 |
| 63 | neuron-neuron synaptic transmission (GO:0007270) | 3.89659919 |
| 64 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.89143582 |
| 65 | innervation (GO:0060384) | 3.88943897 |
| 66 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.88369075 |
| 67 | nephron tubule development (GO:0072080) | 3.87347107 |
| 68 | glutamate secretion (GO:0014047) | 3.86036936 |
| 69 | relaxation of cardiac muscle (GO:0055119) | 3.85672344 |
| 70 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.85099043 |
| 71 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.85056049 |
| 72 | cell communication by electrical coupling (GO:0010644) | 3.84967540 |
| 73 | synaptic transmission, glutamatergic (GO:0035249) | 3.84537565 |
| 74 | regulation of synaptic vesicle transport (GO:1902803) | 3.83031765 |
| 75 | long-term memory (GO:0007616) | 3.81394404 |
| 76 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.78872392 |
| 77 | regulation of synapse structural plasticity (GO:0051823) | 3.77158385 |
| 78 | negative regulation of fatty acid transport (GO:2000192) | 3.76490668 |
| 79 | relaxation of muscle (GO:0090075) | 3.76064533 |
| 80 | cellular sodium ion homeostasis (GO:0006883) | 3.74789845 |
| 81 | behavioral response to ethanol (GO:0048149) | 3.73960635 |
| 82 | response to water (GO:0009415) | 3.70926209 |
| 83 | auditory receptor cell stereocilium organization (GO:0060088) | 3.68948823 |
| 84 | dopamine biosynthetic process (GO:0042416) | 3.66802642 |
| 85 | potassium ion import (GO:0010107) | 3.66668463 |
| 86 | neuronal action potential propagation (GO:0019227) | 3.65717568 |
| 87 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.64651279 |
| 88 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.62238813 |
| 89 | membrane depolarization during action potential (GO:0086010) | 3.61039156 |
| 90 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.58095704 |
| 91 | regulation of potassium ion transmembrane transport (GO:1901379) | 3.57864091 |
| 92 | neurotransmitter transport (GO:0006836) | 3.56709637 |
| 93 | parturition (GO:0007567) | 3.55460009 |
| 94 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.54486578 |
| 95 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.52413569 |
| 96 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.51368017 |
| 97 | cGMP metabolic process (GO:0046068) | 3.50553758 |
| 98 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 3.50058943 |
| 99 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.49554692 |
| 100 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 3.49539229 |
| 101 | membrane repolarization (GO:0086009) | 3.47141855 |
| 102 | adult walking behavior (GO:0007628) | 3.44789183 |
| 103 | regulation of neurotransmitter secretion (GO:0046928) | 3.44675522 |
| 104 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.44617481 |
| 105 | regulation of vesicle fusion (GO:0031338) | 3.43780861 |
| 106 | regulation of neurotransmitter transport (GO:0051588) | 3.42139585 |
| 107 | gamma-aminobutyric acid transport (GO:0015812) | 3.40697246 |
| 108 | renal tubule development (GO:0061326) | 3.40506407 |
| 109 | righting reflex (GO:0060013) | 3.40470125 |
| 110 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 3.40435254 |
| 111 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 3.40435254 |
| 112 | striatum development (GO:0021756) | 3.40229483 |
| 113 | negative regulation of catecholamine secretion (GO:0033604) | 3.36061361 |
| 114 | membrane hyperpolarization (GO:0060081) | 3.33068718 |
| 115 | establishment of synaptic vesicle localization (GO:0097480) | 3.32789657 |
| 116 | synaptic vesicle transport (GO:0048489) | 3.32789657 |
| 117 | retinal cone cell development (GO:0046549) | 3.32015197 |
| 118 | serotonin metabolic process (GO:0042428) | 3.29117497 |
| 119 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.28888216 |
| 120 | synapse assembly (GO:0007416) | 3.28246271 |
| 121 | potassium ion export (GO:0071435) | 3.26619952 |
| 122 | response to histamine (GO:0034776) | 3.26477620 |
| 123 | mating behavior (GO:0007617) | 3.25764240 |
| 124 | regulation of dopamine secretion (GO:0014059) | 3.25009075 |
| 125 | positive regulation of CREB transcription factor activity (GO:0032793) | 3.24476526 |
| 126 | endocrine hormone secretion (GO:0060986) | 3.23063363 |
| 127 | acidic amino acid transport (GO:0015800) | 3.22716767 |
| 128 | regulation of amine transport (GO:0051952) | 3.21660332 |
| 129 | behavioral response to cocaine (GO:0048148) | 3.19909857 |
| 130 | transmission of nerve impulse (GO:0019226) | 3.19780803 |
| 131 | positive regulation of membrane potential (GO:0045838) | 3.19695270 |
| 132 | response to ammonium ion (GO:0060359) | 3.19055906 |
| 133 | nitric oxide biosynthetic process (GO:0006809) | 3.18108671 |
| 134 | regulation of neurotransmitter uptake (GO:0051580) | 3.17544779 |
| 135 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.17187578 |
| 136 | nephron epithelium development (GO:0072009) | 3.15545553 |
| 137 | auditory behavior (GO:0031223) | 3.14171669 |
| 138 | axon cargo transport (GO:0008088) | 3.12458453 |
| 139 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.11648572 |
| 140 | positive regulation of dendritic spine development (GO:0060999) | 3.10650093 |
| 141 | cellular response to ammonium ion (GO:0071242) | 3.09932576 |
| 142 | response to auditory stimulus (GO:0010996) | 3.09550876 |
| 143 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.09538455 |
| 144 | C4-dicarboxylate transport (GO:0015740) | 3.08179129 |
| 145 | negative regulation of heart contraction (GO:0045822) | 3.07331545 |
| 146 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.06333928 |
| 147 | photoreceptor cell development (GO:0042461) | 3.05923310 |
| 148 | calcium ion import (GO:0070509) | 3.05069313 |
| 149 | filopodium assembly (GO:0046847) | 3.04774505 |
| 150 | regulation of neurotransmitter levels (GO:0001505) | 3.03289336 |
| 151 | sodium ion homeostasis (GO:0055078) | 3.02294176 |
| 152 | long term synaptic depression (GO:0060292) | 3.00382683 |
| 153 | primary amino compound metabolic process (GO:1901160) | 3.00267836 |
| 154 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.99087243 |
| 155 | regulation of centriole replication (GO:0046599) | 2.98853266 |
| 156 | L-glutamate transport (GO:0015813) | 2.98815044 |
| 157 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.98279556 |
| 158 | long-term synaptic potentiation (GO:0060291) | 2.97339042 |
| 159 | one-carbon metabolic process (GO:0006730) | 2.96738180 |
| 160 | eye photoreceptor cell development (GO:0042462) | 2.95681422 |
| 161 | sensory perception of taste (GO:0050909) | 2.94957753 |
| 162 | neuron cell-cell adhesion (GO:0007158) | 2.94209152 |
| 163 | regulation of axon regeneration (GO:0048679) | 2.92802090 |
| 164 | regulation of neuron projection regeneration (GO:0070570) | 2.92802090 |
| 165 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.92581858 |
| 166 | regulation of postsynaptic membrane potential (GO:0060078) | 2.91482721 |
| 167 | detection of temperature stimulus (GO:0016048) | 2.89130883 |
| 168 | synaptic transmission (GO:0007268) | 2.86468284 |
| 169 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.86099178 |
| 170 | short-term memory (GO:0007614) | 10.9722809 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 5.28938827 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.24192753 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.63964241 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.13453200 |
| 5 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.99546150 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.91668987 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.79403451 |
| 8 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.76669921 |
| 9 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.72014069 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.71635220 |
| 11 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.71635220 |
| 12 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.71045710 |
| 13 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.70878895 |
| 14 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.63362755 |
| 15 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.62817603 |
| 16 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.58908654 |
| 17 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.55879267 |
| 18 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.53486887 |
| 19 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.49934036 |
| 20 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.42756021 |
| 21 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.40073996 |
| 22 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.35865118 |
| 23 | FUS_26573619_Chip-Seq_HEK293_Human | 2.32195003 |
| 24 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.24536638 |
| 25 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.23587773 |
| 26 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.22653503 |
| 27 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.19240417 |
| 28 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.17992119 |
| 29 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.16834433 |
| 30 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.11871771 |
| 31 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.01054008 |
| 32 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.99020306 |
| 33 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.93322131 |
| 34 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.88674519 |
| 35 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.85873915 |
| 36 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.79556444 |
| 37 | VDR_22108803_ChIP-Seq_LS180_Human | 1.76323914 |
| 38 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.74106863 |
| 39 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.71659091 |
| 40 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.65116275 |
| 41 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.61207542 |
| 42 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.57616852 |
| 43 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.56284418 |
| 44 | AR_25329375_ChIP-Seq_VCAP_Human | 1.51240401 |
| 45 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.50465611 |
| 46 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.49553461 |
| 47 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.48022476 |
| 48 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.47449375 |
| 49 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.47108691 |
| 50 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.42528620 |
| 51 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.39460121 |
| 52 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.38791532 |
| 53 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.37365218 |
| 54 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.36749702 |
| 55 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.36195801 |
| 56 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.35581394 |
| 57 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.29944870 |
| 58 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.29779861 |
| 59 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.29779523 |
| 60 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.29101097 |
| 61 | STAT3_23295773_ChIP-Seq_U87_Human | 1.28963732 |
| 62 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.25652864 |
| 63 | P300_19829295_ChIP-Seq_ESCs_Human | 1.25288560 |
| 64 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.24713094 |
| 65 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.24207931 |
| 66 | AR_19668381_ChIP-Seq_PC3_Human | 1.24094205 |
| 67 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.22308690 |
| 68 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.21501900 |
| 69 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.20928592 |
| 70 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20883336 |
| 71 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.20281369 |
| 72 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.20072069 |
| 73 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.18825365 |
| 74 | TCF4_23295773_ChIP-Seq_U87_Human | 1.18787699 |
| 75 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.16480381 |
| 76 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.14178154 |
| 77 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.11332218 |
| 78 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.10238306 |
| 79 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.10203568 |
| 80 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.10102211 |
| 81 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.09449778 |
| 82 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.09262361 |
| 83 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.09244489 |
| 84 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.08779598 |
| 85 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.08694325 |
| 86 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.08321705 |
| 87 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.06518168 |
| 88 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06430021 |
| 89 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.04399312 |
| 90 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.03547236 |
| 91 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.02909722 |
| 92 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.02758733 |
| 93 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.02630512 |
| 94 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.01276492 |
| 95 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.00795829 |
| 96 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.99718248 |
| 97 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.99689710 |
| 98 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99075553 |
| 99 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.99075553 |
| 100 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98495355 |
| 101 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.97879794 |
| 102 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.97485788 |
| 103 | KDM2B_26808549_Chip-Seq_K562_Human | 0.96810938 |
| 104 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.96129986 |
| 105 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.95595859 |
| 106 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95060615 |
| 107 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.94911820 |
| 108 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.94809099 |
| 109 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.94335390 |
| 110 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.94254160 |
| 111 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.93228065 |
| 112 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.93083081 |
| 113 | EWS_26573619_Chip-Seq_HEK293_Human | 0.91771707 |
| 114 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.91701575 |
| 115 | TBL1_22424771_ChIP-Seq_293T_Human | 0.91510949 |
| 116 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.91508571 |
| 117 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.91222230 |
| 118 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.90802074 |
| 119 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.90650372 |
| 120 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.89314014 |
| 121 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.89293119 |
| 122 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.88220733 |
| 123 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.86339209 |
| 124 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.86259325 |
| 125 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.85607272 |
| 126 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.85309531 |
| 127 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.82751104 |
| 128 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.82131867 |
| 129 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82114452 |
| 130 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.81428547 |
| 131 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.81415941 |
| 132 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.80027230 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001984_abnormal_olfaction | 5.18709711 |
| 2 | MP0009046_muscle_twitch | 4.51775004 |
| 3 | MP0005551_abnormal_eye_electrophysiolog | 4.48143339 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.21653755 |
| 5 | MP0004859_abnormal_synaptic_plasticity | 3.16358179 |
| 6 | MP0006072_abnormal_retinal_apoptosis | 3.05443017 |
| 7 | MP0008569_lethality_at_weaning | 3.04801929 |
| 8 | MP0002272_abnormal_nervous_system | 2.99233057 |
| 9 | MP0002090_abnormal_vision | 2.98211789 |
| 10 | MP0001188_hyperpigmentation | 2.90432953 |
| 11 | MP0003880_abnormal_central_pattern | 2.76633997 |
| 12 | MP0008875_abnormal_xenobiotic_pharmacok | 2.76416557 |
| 13 | MP0002067_abnormal_sensory_capabilities | 2.54456853 |
| 14 | MP0002064_seizures | 2.50161976 |
| 15 | MP0005410_abnormal_fertilization | 2.49021067 |
| 16 | MP0006292_abnormal_olfactory_placode | 2.47217353 |
| 17 | MP0005423_abnormal_somatic_nervous | 2.47172146 |
| 18 | MP0002734_abnormal_mechanical_nocicepti | 2.43065317 |
| 19 | MP0009745_abnormal_behavioral_response | 2.39726095 |
| 20 | MP0002184_abnormal_innervation | 2.36759683 |
| 21 | MP0010386_abnormal_urinary_bladder | 2.32719518 |
| 22 | MP0008874_decreased_physiological_sensi | 2.28297942 |
| 23 | MP0001502_abnormal_circadian_rhythm | 2.25484222 |
| 24 | MP0001486_abnormal_startle_reflex | 2.25031835 |
| 25 | MP0004742_abnormal_vestibular_system | 2.23069270 |
| 26 | MP0002063_abnormal_learning/memory/cond | 2.21237993 |
| 27 | MP0003787_abnormal_imprinting | 2.10939380 |
| 28 | MP0005253_abnormal_eye_physiology | 2.08520156 |
| 29 | MP0004142_abnormal_muscle_tone | 2.06541771 |
| 30 | MP0001968_abnormal_touch/_nociception | 2.05396370 |
| 31 | MP0004145_abnormal_muscle_electrophysio | 2.01253278 |
| 32 | MP0001501_abnormal_sleep_pattern | 1.95344873 |
| 33 | MP0002572_abnormal_emotion/affect_behav | 1.93740750 |
| 34 | MP0004215_abnormal_myocardial_fiber | 1.90649345 |
| 35 | MP0002909_abnormal_adrenal_gland | 1.85697823 |
| 36 | MP0003879_abnormal_hair_cell | 1.85433731 |
| 37 | MP0001440_abnormal_grooming_behavior | 1.79854683 |
| 38 | MP0004484_altered_response_of | 1.76596481 |
| 39 | MP0000013_abnormal_adipose_tissue | 1.70249642 |
| 40 | MP0008004_abnormal_stomach_pH | 1.66973102 |
| 41 | MP0002638_abnormal_pupillary_reflex | 1.66570534 |
| 42 | MP0004036_abnormal_muscle_relaxation | 1.63773803 |
| 43 | MP0006276_abnormal_autonomic_nervous | 1.61525332 |
| 44 | MP0002229_neurodegeneration | 1.59855157 |
| 45 | MP0002822_catalepsy | 1.59232850 |
| 46 | MP0004233_abnormal_muscle_weight | 1.58600132 |
| 47 | MP0002736_abnormal_nociception_after | 1.56724919 |
| 48 | MP0004270_analgesia | 1.48697518 |
| 49 | MP0005195_abnormal_posterior_eye | 1.47339611 |
| 50 | MP0004924_abnormal_behavior | 1.43865509 |
| 51 | MP0005386_behavior/neurological_phenoty | 1.43865509 |
| 52 | MP0002557_abnormal_social/conspecific_i | 1.43151414 |
| 53 | MP0004084_abnormal_cardiac_muscle | 1.40426539 |
| 54 | MP0002882_abnormal_neuron_morphology | 1.39853396 |
| 55 | MP0000358_abnormal_cell_content/ | 1.35975610 |
| 56 | MP0003950_abnormal_plasma_membrane | 1.34666927 |
| 57 | MP0000955_abnormal_spinal_cord | 1.29170173 |
| 58 | MP0004885_abnormal_endolymph | 1.29094415 |
| 59 | MP0002735_abnormal_chemical_nociception | 1.23144666 |
| 60 | MP0001970_abnormal_pain_threshold | 1.22925127 |
| 61 | MP0000566_synostosis | 1.22439674 |
| 62 | MP0002066_abnormal_motor_capabilities/c | 1.21000505 |
| 63 | MP0005248_abnormal_Harderian_gland | 1.18505216 |
| 64 | MP0002752_abnormal_somatic_nervous | 1.18275442 |
| 65 | MP0008877_abnormal_DNA_methylation | 1.17220599 |
| 66 | MP0005499_abnormal_olfactory_system | 1.16508949 |
| 67 | MP0005394_taste/olfaction_phenotype | 1.16508949 |
| 68 | MP0000003_abnormal_adipose_tissue | 1.11098846 |
| 69 | MP0001346_abnormal_lacrimal_gland | 1.09253940 |
| 70 | MP0004811_abnormal_neuron_physiology | 1.07993585 |
| 71 | MP0005409_darkened_coat_color | 1.06405219 |
| 72 | MP0003633_abnormal_nervous_system | 1.06235606 |
| 73 | MP0009697_abnormal_copulation | 1.01614681 |
| 74 | MP0003632_abnormal_nervous_system | 0.95696708 |
| 75 | MP0008872_abnormal_physiological_respon | 0.95645223 |
| 76 | MP0004043_abnormal_pH_regulation | 0.94591625 |
| 77 | MP0003631_nervous_system_phenotype | 0.94248665 |
| 78 | MP0001529_abnormal_vocalization | 0.92970817 |
| 79 | MP0001485_abnormal_pinna_reflex | 0.92273729 |
| 80 | MP0004147_increased_porphyrin_level | 0.89485228 |
| 81 | MP0000569_abnormal_digit_pigmentation | 0.89484640 |
| 82 | MP0005646_abnormal_pituitary_gland | 0.86629576 |
| 83 | MP0000343_altered_response_to | 0.86206890 |
| 84 | MP0003329_amyloid_beta_deposits | 0.84971393 |
| 85 | MP0002089_abnormal_postnatal_growth/wei | 0.83733214 |
| 86 | MP0000751_myopathy | 0.82938674 |
| 87 | MP0002152_abnormal_brain_morphology | 0.81665316 |
| 88 | MP0001765_abnormal_ion_homeostasis | 0.80523379 |
| 89 | MP0003868_abnormal_feces_composition | 0.78938748 |
| 90 | MP0002277_abnormal_respiratory_mucosa | 0.78468520 |
| 91 | MP0003122_maternal_imprinting | 0.77243573 |
| 92 | MP0000778_abnormal_nervous_system | 0.77194233 |
| 93 | MP0001324_abnormal_eye_pigmentation | 0.77148221 |
| 94 | MP0003137_abnormal_impulse_conducting | 0.76430460 |
| 95 | MP0002733_abnormal_thermal_nociception | 0.75808708 |
| 96 | MP0005595_abnormal_vascular_smooth | 0.75678275 |
| 97 | MP0001963_abnormal_hearing_physiology | 0.75618665 |
| 98 | MP0006035_abnormal_mitochondrial_morpho | 0.75611581 |
| 99 | MP0000631_abnormal_neuroendocrine_gland | 0.75278722 |
| 100 | MP0000230_abnormal_systemic_arterial | 0.75144241 |
| 101 | MP0005623_abnormal_meninges_morphology | 0.73704003 |
| 102 | MP0008789_abnormal_olfactory_epithelium | 0.73603376 |
| 103 | MP0003011_delayed_dark_adaptation | 0.72779086 |
| 104 | MP0003698_abnormal_male_reproductive | 0.71012566 |
| 105 | MP0005171_absent_coat_pigmentation | 0.69963497 |
| 106 | MP0005391_vision/eye_phenotype | 0.69381376 |
| 107 | MP0003634_abnormal_glial_cell | 0.67127979 |
| 108 | MP0004085_abnormal_heartbeat | 0.66175103 |
| 109 | MP0002234_abnormal_pharynx_morphology | 0.65629348 |
| 110 | MP0003866_abnormal_defecation | 0.65324506 |
| 111 | MP0009379_abnormal_foot_pigmentation | 0.65133585 |
| 112 | MP0000534_abnormal_ureter_morphology | 0.63074033 |
| 113 | MP0002069_abnormal_eating/drinking_beha | 0.62428048 |
| 114 | MP0010329_abnormal_lipoprotein_level | 0.61958251 |
| 115 | MP0005187_abnormal_penis_morphology | 0.59562106 |
| 116 | MP0008775_abnormal_heart_ventricle | 0.59029167 |
| 117 | MP0000538_abnormal_urinary_bladder | 0.58429344 |
| 118 | MP0002332_abnormal_exercise_endurance | 0.58203198 |
| 119 | MP0000015_abnormal_ear_pigmentation | 0.57794529 |
| 120 | MP0005535_abnormal_body_temperature | 0.56295187 |
| 121 | MP0005464_abnormal_platelet_physiology | 0.56092307 |
| 122 | MP0000920_abnormal_myelination | 0.55827065 |
| 123 | MP0005174_abnormal_tail_pigmentation | 0.53938076 |
| 124 | MP0005620_abnormal_muscle_contractility | 0.53815048 |
| 125 | MP0000749_muscle_degeneration | 0.44989855 |
| 126 | MP0001986_abnormal_taste_sensitivity | 0.44989332 |
| 127 | MP0002083_premature_death | 0.44632221 |
| 128 | MP0002972_abnormal_cardiac_muscle | 0.44044577 |
| 129 | MP0001756_abnormal_urination | 0.43020384 |
| 130 | MP0002161_abnormal_fertility/fecundity | 0.41198594 |
| 131 | MP0003956_abnormal_body_size | 0.40124527 |
| 132 | MP0003638_abnormal_response/metabolism_ | 0.39644493 |
| 133 | MP0001299_abnormal_eye_distance/ | 0.38978775 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Progressive cerebellar ataxia (HP:0002073) | 7.75556062 |
| 2 | Action tremor (HP:0002345) | 5.99708892 |
| 3 | Absence seizures (HP:0002121) | 5.91543470 |
| 4 | Febrile seizures (HP:0002373) | 5.81255236 |
| 5 | Abnormality of macular pigmentation (HP:0008002) | 5.71299586 |
| 6 | Epileptic encephalopathy (HP:0200134) | 5.46186905 |
| 7 | Myokymia (HP:0002411) | 5.35977372 |
| 8 | Central scotoma (HP:0000603) | 5.23547903 |
| 9 | Dysdiadochokinesis (HP:0002075) | 5.08033898 |
| 10 | Focal motor seizures (HP:0011153) | 4.85129405 |
| 11 | Dialeptic seizures (HP:0011146) | 4.68423715 |
| 12 | Gaze-evoked nystagmus (HP:0000640) | 4.55134750 |
| 13 | Atonic seizures (HP:0010819) | 4.47978134 |
| 14 | Decreased central vision (HP:0007663) | 4.44288071 |
| 15 | Visual hallucinations (HP:0002367) | 4.08759827 |
| 16 | Scanning speech (HP:0002168) | 4.00856619 |
| 17 | Severe visual impairment (HP:0001141) | 3.90708623 |
| 18 | Cholecystitis (HP:0001082) | 3.85178815 |
| 19 | Abnormal gallbladder physiology (HP:0012438) | 3.85178815 |
| 20 | Focal seizures (HP:0007359) | 3.83050065 |
| 21 | Dysmetric saccades (HP:0000641) | 3.77208412 |
| 22 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.69528948 |
| 23 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.69528948 |
| 24 | Dysmetria (HP:0001310) | 3.68529665 |
| 25 | Increased corneal curvature (HP:0100692) | 3.67985715 |
| 26 | Keratoconus (HP:0000563) | 3.67985715 |
| 27 | Generalized tonic-clonic seizures (HP:0002069) | 3.64179493 |
| 28 | Acute necrotizing encephalopathy (HP:0006965) | 3.62466967 |
| 29 | Scotoma (HP:0000575) | 3.41258137 |
| 30 | Horizontal nystagmus (HP:0000666) | 3.41241684 |
| 31 | Depression (HP:0000716) | 3.37761880 |
| 32 | Hemiparesis (HP:0001269) | 3.33419914 |
| 33 | Hemiplegia (HP:0002301) | 3.28899576 |
| 34 | Septo-optic dysplasia (HP:0100842) | 3.28653356 |
| 35 | Hyperlipoproteinemia (HP:0010980) | 3.26474639 |
| 36 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.26125715 |
| 37 | Truncal ataxia (HP:0002078) | 3.11517757 |
| 38 | Abnormality of ocular smooth pursuit (HP:0000617) | 3.06585899 |
| 39 | Progressive macrocephaly (HP:0004481) | 3.04694587 |
| 40 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.03034298 |
| 41 | Impaired smooth pursuit (HP:0007772) | 2.98463540 |
| 42 | Acute encephalopathy (HP:0006846) | 2.87216832 |
| 43 | Anxiety (HP:0000739) | 2.86497446 |
| 44 | Diplopia (HP:0000651) | 2.86324363 |
| 45 | Abnormality of binocular vision (HP:0011514) | 2.86324363 |
| 46 | Impaired vibratory sensation (HP:0002495) | 2.85649747 |
| 47 | Abnormality of the corticospinal tract (HP:0002492) | 2.85643808 |
| 48 | EEG with generalized epileptiform discharges (HP:0011198) | 2.80558885 |
| 49 | Ventricular fibrillation (HP:0001663) | 2.77112928 |
| 50 | Dyschromatopsia (HP:0007641) | 2.73445585 |
| 51 | Intention tremor (HP:0002080) | 2.73182958 |
| 52 | Genetic anticipation (HP:0003743) | 2.72636344 |
| 53 | Epileptiform EEG discharges (HP:0011182) | 2.72252182 |
| 54 | Mitochondrial inheritance (HP:0001427) | 2.69442690 |
| 55 | Limb ataxia (HP:0002070) | 2.50437608 |
| 56 | Broad-based gait (HP:0002136) | 2.50084170 |
| 57 | Status epilepticus (HP:0002133) | 2.46160589 |
| 58 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.38302955 |
| 59 | Autoamputation (HP:0001218) | 2.37707577 |
| 60 | Mutism (HP:0002300) | 2.36438543 |
| 61 | Incomplete penetrance (HP:0003829) | 2.34680522 |
| 62 | Abnormal pupillary function (HP:0007686) | 2.30490482 |
| 63 | Renal Fanconi syndrome (HP:0001994) | 2.27666287 |
| 64 | Abnormal eating behavior (HP:0100738) | 2.23567687 |
| 65 | Prolonged QT interval (HP:0001657) | 2.22055669 |
| 66 | Insidious onset (HP:0003587) | 2.21783852 |
| 67 | Termporal pattern (HP:0011008) | 2.21783852 |
| 68 | Increased hepatocellular lipid droplets (HP:0006565) | 2.20418092 |
| 69 | Postural tremor (HP:0002174) | 2.18810922 |
| 70 | Optic nerve hypoplasia (HP:0000609) | 2.17392722 |
| 71 | Tetraplegia (HP:0002445) | 2.15266576 |
| 72 | Cerebellar atrophy (HP:0001272) | 2.15143978 |
| 73 | Abnormality of alanine metabolism (HP:0010916) | 2.11077793 |
| 74 | Hyperalaninemia (HP:0003348) | 2.11077793 |
| 75 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.11077793 |
| 76 | Abnormality of saccadic eye movements (HP:0000570) | 2.08898779 |
| 77 | Cerebral edema (HP:0002181) | 2.07258507 |
| 78 | Hypoplasia of the fovea (HP:0007750) | 2.07152822 |
| 79 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.07152822 |
| 80 | Amblyopia (HP:0000646) | 2.05662721 |
| 81 | Slow progression (HP:0003677) | 2.05220630 |
| 82 | Choroideremia (HP:0001139) | 2.03327215 |
| 83 | Increased CSF lactate (HP:0002490) | 2.02234511 |
| 84 | Congenital stationary night blindness (HP:0007642) | 10.1116904 |
| 85 | Abolished electroretinogram (ERG) (HP:0000550) | 1.96664494 |
| 86 | Increased serum pyruvate (HP:0003542) | 1.96247480 |
| 87 | Pendular nystagmus (HP:0012043) | 1.93550180 |
| 88 | Abnormality of the anterior horn cell (HP:0006802) | 1.93110770 |
| 89 | Degeneration of anterior horn cells (HP:0002398) | 1.93110770 |
| 90 | Gait ataxia (HP:0002066) | 1.92260187 |
| 91 | Torticollis (HP:0000473) | 1.90811828 |
| 92 | Focal dystonia (HP:0004373) | 1.90779777 |
| 93 | Oligodactyly (hands) (HP:0001180) | 1.88448003 |
| 94 | Retinal dysplasia (HP:0007973) | 1.87578333 |
| 95 | Exercise-induced myalgia (HP:0003738) | 1.86509173 |
| 96 | Hyperventilation (HP:0002883) | 1.86058097 |
| 97 | Dysarthria (HP:0001260) | 1.84558767 |
| 98 | Syncope (HP:0001279) | 1.83613324 |
| 99 | Impaired social interactions (HP:0000735) | 1.83450177 |
| 100 | Abnormal social behavior (HP:0012433) | 1.83450177 |
| 101 | Athetosis (HP:0002305) | 1.82087115 |
| 102 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.81824452 |
| 103 | Abnormal EKG (HP:0003115) | 1.81629517 |
| 104 | Attenuation of retinal blood vessels (HP:0007843) | 1.81472254 |
| 105 | Lipid accumulation in hepatocytes (HP:0006561) | 1.80699005 |
| 106 | Supranuclear gaze palsy (HP:0000605) | 1.79399730 |
| 107 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 1.78529924 |
| 108 | Abnormality of the fovea (HP:0000493) | 1.78397101 |
| 109 | Hypsarrhythmia (HP:0002521) | 1.78284117 |
| 110 | Neoplasm of the heart (HP:0100544) | 1.73551627 |
| 111 | Esotropia (HP:0000565) | 1.72714537 |
| 112 | Polyphagia (HP:0002591) | 1.72234699 |
| 113 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.71823335 |
| 114 | Poor eye contact (HP:0000817) | 1.70933530 |
| 115 | Hypoplastic nipples (HP:0002557) | 1.68972927 |
| 116 | Atrial fibrillation (HP:0005110) | 1.67512283 |
| 117 | Abnormality of glycolysis (HP:0004366) | 1.67011777 |
| 118 | Absent septum pellucidum (HP:0001331) | 1.66703208 |
| 119 | Abnormality of the lower motor neuron (HP:0002366) | 1.65647369 |
| 120 | Photophobia (HP:0000613) | 1.64972201 |
| 121 | Narrow nasal bridge (HP:0000446) | 1.64859219 |
| 122 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.64752546 |
| 123 | Cholelithiasis (HP:0001081) | 1.64737427 |
| 124 | Generalized myoclonic seizures (HP:0002123) | 1.63183770 |
| 125 | Ankle clonus (HP:0011448) | 1.62445905 |
| 126 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.61785173 |
| 127 | Increased intramyocellular lipid droplets (HP:0012240) | 1.60871797 |
| 128 | Abnormality of the septum pellucidum (HP:0007375) | 1.59446471 |
| 129 | Optic disc pallor (HP:0000543) | 1.59422408 |
| 130 | Annular pancreas (HP:0001734) | 1.58243824 |
| 131 | Intellectual disability, mild (HP:0001256) | 1.53358292 |
| 132 | Leukodystrophy (HP:0002415) | 1.53068318 |
| 133 | Exertional dyspnea (HP:0002875) | 1.52088660 |
| 134 | Epidermoid cyst (HP:0200040) | 1.51404365 |
| 135 | Distal lower limb amyotrophy (HP:0008944) | 1.44876107 |
| 136 | Skin nodule (HP:0200036) | 1.42640905 |
| 137 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.41817328 |
| 138 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.40648591 |
| 139 | Congenital onset (HP:0003577) | 1.40442584 |
| 140 | X-linked dominant inheritance (HP:0001423) | 1.35781548 |
| 141 | Prolonged bleeding time (HP:0003010) | 1.35055544 |
| 142 | Exercise intolerance (HP:0003546) | 1.35026975 |
| 143 | Heterochromia iridis (HP:0001100) | 1.34316557 |
| 144 | Abnormality of renal resorption (HP:0011038) | 1.32571164 |
| 145 | Urinary urgency (HP:0000012) | 1.29065989 |
| 146 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.28646129 |
| 147 | Aplasia of the phalanges of the hand (HP:0009802) | 1.28646129 |
| 148 | Aplasia involving bones of the extremities (HP:0009825) | 1.28646129 |
| 149 | Progressive inability to walk (HP:0002505) | 1.27577358 |
| 150 | Respiratory failure (HP:0002878) | 1.25817743 |
| 151 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.25581917 |
| 152 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.25581917 |
| 153 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.25242168 |
| 154 | Increased muscle lipid content (HP:0009058) | 1.24265213 |
| 155 | Abnormality of lateral ventricle (HP:0030047) | 1.17305546 |
| 156 | Inability to walk (HP:0002540) | 1.15138436 |
| 157 | Xanthomatosis (HP:0000991) | 1.14009271 |
| 158 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.13830231 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K12 | 8.34585528 |
| 2 | PBK | 4.62882782 |
| 3 | RIPK1 | 4.51641121 |
| 4 | NME1 | 3.66930392 |
| 5 | MYLK | 3.57381705 |
| 6 | PAK6 | 3.03007132 |
| 7 | PRPF4B | 2.96347071 |
| 8 | CAMKK2 | 2.73452415 |
| 9 | TAOK2 | 2.56379730 |
| 10 | ARAF | 2.56063127 |
| 11 | CSNK1G3 | 2.41144633 |
| 12 | MINK1 | 2.40943541 |
| 13 | NEK1 | 2.40724230 |
| 14 | STK38 | 2.40714904 |
| 15 | TTK | 2.38988265 |
| 16 | CSNK1G2 | 2.37486870 |
| 17 | PINK1 | 2.32307842 |
| 18 | CSNK1A1L | 2.30361503 |
| 19 | TESK1 | 2.26180071 |
| 20 | MAP3K4 | 2.24698224 |
| 21 | CDK3 | 2.12253889 |
| 22 | MAP2K7 | 1.99162722 |
| 23 | MARK1 | 1.91505604 |
| 24 | CSNK1G1 | 1.86862350 |
| 25 | PHKG2 | 1.71005880 |
| 26 | PHKG1 | 1.71005880 |
| 27 | CAMKK1 | 1.68361955 |
| 28 | DYRK1A | 1.64136770 |
| 29 | WNK1 | 1.56057418 |
| 30 | TNIK | 1.55858112 |
| 31 | PAK4 | 1.53597769 |
| 32 | IRAK1 | 1.50925929 |
| 33 | NTRK3 | 1.48965152 |
| 34 | PNCK | 1.46074982 |
| 35 | MAP3K13 | 1.44307945 |
| 36 | MAP3K9 | 1.42043021 |
| 37 | PRKCG | 1.34392599 |
| 38 | CLK1 | 1.33373282 |
| 39 | CAMK2D | 1.30078344 |
| 40 | DAPK2 | 1.25618024 |
| 41 | CAMK1G | 1.24554303 |
| 42 | NTRK2 | 1.20901003 |
| 43 | TNK2 | 1.20413122 |
| 44 | FES | 1.18663102 |
| 45 | STK38L | 1.17456427 |
| 46 | MAP2K4 | 1.16813681 |
| 47 | BRAF | 1.15610161 |
| 48 | MAPK7 | 1.14186602 |
| 49 | CAMK1 | 1.13648238 |
| 50 | DAPK1 | 1.13631150 |
| 51 | ILK | 1.08008090 |
| 52 | MAP4K2 | 1.06242989 |
| 53 | INSRR | 0.99473455 |
| 54 | SGK494 | 0.98746064 |
| 55 | SGK223 | 0.98746064 |
| 56 | PRKG1 | 0.97285094 |
| 57 | EIF2AK1 | 0.97116988 |
| 58 | CDK14 | 0.95562646 |
| 59 | CAMK1D | 0.91482371 |
| 60 | SIK2 | 0.91138196 |
| 61 | ERBB3 | 0.88404049 |
| 62 | MAP3K7 | 0.88370309 |
| 63 | CDK15 | 0.87706874 |
| 64 | PRKAA1 | 0.86213590 |
| 65 | CDK5 | 0.84603338 |
| 66 | MAP3K11 | 0.84444496 |
| 67 | CDK18 | 0.83058178 |
| 68 | CDK19 | 0.81585697 |
| 69 | PTK6 | 0.79937411 |
| 70 | CAMK2A | 0.79609243 |
| 71 | RIPK4 | 0.78785537 |
| 72 | PRKCH | 0.77737493 |
| 73 | EPHA4 | 0.77622431 |
| 74 | CDK11A | 0.75871985 |
| 75 | SIK3 | 0.74279643 |
| 76 | GRK5 | 0.74170422 |
| 77 | CSNK1A1 | 0.72927155 |
| 78 | CAMK2G | 0.71152354 |
| 79 | CAMK4 | 0.70293519 |
| 80 | TAF1 | 0.70145887 |
| 81 | PRKCA | 0.69267157 |
| 82 | DAPK3 | 0.68633323 |
| 83 | PRKG2 | 0.66936808 |
| 84 | ITK | 0.66625213 |
| 85 | MAPK13 | 0.66098739 |
| 86 | CASK | 0.65880450 |
| 87 | TRIM28 | 0.64874303 |
| 88 | UHMK1 | 0.64861535 |
| 89 | PRKACA | 0.63546750 |
| 90 | AKT3 | 0.62486310 |
| 91 | LIMK1 | 0.61534323 |
| 92 | PRKCZ | 0.60154913 |
| 93 | DYRK1B | 0.58195540 |
| 94 | FER | 0.57819184 |
| 95 | PRKCE | 0.56774763 |
| 96 | ROCK2 | 0.56655678 |
| 97 | PDK1 | 0.53204630 |
| 98 | WNK4 | 0.51452527 |
| 99 | CSNK1D | 0.50841331 |
| 100 | PRKDC | 0.50573266 |
| 101 | BMPR2 | 0.50402476 |
| 102 | KSR1 | 0.49827745 |
| 103 | MARK2 | 0.49522666 |
| 104 | STK11 | 0.49486226 |
| 105 | IRAK2 | 0.49101948 |
| 106 | MAPK12 | 0.49010836 |
| 107 | SGK2 | 0.48606327 |
| 108 | CDC42BPA | 0.48404563 |
| 109 | RPS6KA3 | 0.47199133 |
| 110 | PRKCB | 0.47157310 |
| 111 | MOS | 0.44026277 |
| 112 | KSR2 | 0.43795928 |
| 113 | CAMK2B | 0.43004553 |
| 114 | SIK1 | 0.42164463 |
| 115 | PLK4 | 0.41302885 |
| 116 | SRC | 0.41216314 |
| 117 | PKN1 | 0.40984626 |
| 118 | SCYL2 | 0.40811194 |
| 119 | PLK2 | 0.40346713 |
| 120 | MAPK10 | 0.39803054 |
| 121 | CHEK2 | 0.39670479 |
| 122 | STK16 | 0.39390656 |
| 123 | YES1 | 0.38798686 |
| 124 | OXSR1 | 0.38342034 |
| 125 | GRK1 | 0.37068108 |
| 126 | GSK3B | 0.36719827 |
| 127 | MST4 | 0.35513068 |
| 128 | RAF1 | 0.34066490 |
| 129 | FYN | 0.33779087 |
| 130 | PRKACG | 0.32506086 |
| 131 | PAK3 | 0.32495503 |
| 132 | MAPK8 | 0.31960210 |
| 133 | MAP3K1 | 0.31641138 |
| 134 | ALK | 0.31310095 |
| 135 | CSNK1E | 0.30717412 |
| 136 | MAPK1 | 0.30675872 |
| 137 | STK39 | 0.29640258 |
| 138 | BCR | 0.24293175 |
| 139 | CSF1R | 0.23411452 |
| 140 | BMPR1B | 0.22157745 |
| 141 | TSSK6 | 0.21600159 |
| 142 | LCK | 0.21115930 |
| 143 | FGR | 0.20563971 |
| 144 | RPS6KB1 | 0.20472431 |
| 145 | SGK1 | 0.19131922 |
| 146 | CCNB1 | 0.19109502 |
| 147 | ROCK1 | 0.19026536 |
| 148 | BTK | 0.18668328 |
| 149 | PRKCD | 0.18659467 |
| 150 | SYK | 0.17466911 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.96829916 |
| 2 | GABAergic synapse_Homo sapiens_hsa04727 | 4.07311277 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 3.72594322 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.65873262 |
| 5 | Morphine addiction_Homo sapiens_hsa05032 | 3.59743271 |
| 6 | Taste transduction_Homo sapiens_hsa04742 | 3.10486522 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 3.00170686 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.98927246 |
| 9 | Olfactory transduction_Homo sapiens_hsa04740 | 2.42048861 |
| 10 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.32781498 |
| 11 | Long-term depression_Homo sapiens_hsa04730 | 2.31900523 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.14094320 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.02931510 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 1.96188778 |
| 15 | Circadian rhythm_Homo sapiens_hsa04710 | 1.95283999 |
| 16 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.91542329 |
| 17 | Parkinsons disease_Homo sapiens_hsa05012 | 1.88637286 |
| 18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.87339249 |
| 19 | Long-term potentiation_Homo sapiens_hsa04720 | 1.81451303 |
| 20 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.75644967 |
| 21 | Renin secretion_Homo sapiens_hsa04924 | 1.53091193 |
| 22 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.52342830 |
| 23 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.51595055 |
| 24 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.47482418 |
| 25 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.45005302 |
| 26 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.44206646 |
| 27 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.39584945 |
| 28 | Huntingtons disease_Homo sapiens_hsa05016 | 1.38954554 |
| 29 | Phototransduction_Homo sapiens_hsa04744 | 1.36374568 |
| 30 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.36198169 |
| 31 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.30795818 |
| 32 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.30363635 |
| 33 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.28930732 |
| 34 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.26236520 |
| 35 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.21372444 |
| 36 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.19078362 |
| 37 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.18221846 |
| 38 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.13783615 |
| 39 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.11449576 |
| 40 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.09190957 |
| 41 | Gap junction_Homo sapiens_hsa04540 | 1.05473731 |
| 42 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.02158100 |
| 43 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.99800819 |
| 44 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.96909321 |
| 45 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.91136836 |
| 46 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.90631991 |
| 47 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.88201019 |
| 48 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.86934084 |
| 49 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.84187689 |
| 50 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.79859659 |
| 51 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.79764482 |
| 52 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.77574697 |
| 53 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.74931321 |
| 54 | Mineral absorption_Homo sapiens_hsa04978 | 0.72836852 |
| 55 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.72056096 |
| 56 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.64602853 |
| 57 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.63888569 |
| 58 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.60467899 |
| 59 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.60338032 |
| 60 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.58123955 |
| 61 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.57296355 |
| 62 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.56651557 |
| 63 | Alcoholism_Homo sapiens_hsa05034 | 0.55501609 |
| 64 | Cocaine addiction_Homo sapiens_hsa05030 | 0.55413770 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52990516 |
| 66 | Platelet activation_Homo sapiens_hsa04611 | 0.52289173 |
| 67 | Bile secretion_Homo sapiens_hsa04976 | 0.50651377 |
| 68 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.49073230 |
| 69 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.48789663 |
| 70 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.46531055 |
| 71 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.46406264 |
| 72 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.46152960 |
| 73 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.43457354 |
| 74 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.43204660 |
| 75 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.41136618 |
| 76 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.40637094 |
| 77 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.39956158 |
| 78 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.37880570 |
| 79 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.36909951 |
| 80 | Alzheimers disease_Homo sapiens_hsa05010 | 0.36546371 |
| 81 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.35110876 |
| 82 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.34597098 |
| 83 | Glioma_Homo sapiens_hsa05214 | 0.33871568 |
| 84 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.33614528 |
| 85 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.33303907 |
| 86 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.32764604 |
| 87 | Protein export_Homo sapiens_hsa03060 | 0.32019209 |
| 88 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.31851723 |
| 89 | Melanogenesis_Homo sapiens_hsa04916 | 0.31147232 |
| 90 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.30974795 |
| 91 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.29736406 |
| 92 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.28839228 |
| 93 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.28686112 |
| 94 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.27399229 |
| 95 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.27179603 |
| 96 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.26295699 |
| 97 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.26082620 |
| 98 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.23648713 |
| 99 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.20639178 |
| 100 | Prion diseases_Homo sapiens_hsa05020 | 0.20532247 |
| 101 | Axon guidance_Homo sapiens_hsa04360 | 0.19406014 |
| 102 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.19250587 |
| 103 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.19149558 |
| 104 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.18798164 |
| 105 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.17638829 |
| 106 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.17597575 |
| 107 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.16580365 |
| 108 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.16436321 |
| 109 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.14054368 |
| 110 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.13713866 |
| 111 | Endocytosis_Homo sapiens_hsa04144 | 0.13525717 |
| 112 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.13354761 |
| 113 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.13231089 |
| 114 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.12169243 |
| 115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.12066472 |
| 116 | Carbon metabolism_Homo sapiens_hsa01200 | 0.12031147 |
| 117 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.07544908 |
| 118 | ABC transporters_Homo sapiens_hsa02010 | 0.07486406 |
| 119 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.07407492 |
| 120 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.06164782 |
| 121 | Retinol metabolism_Homo sapiens_hsa00830 | 0.02926945 |
| 122 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.02417863 |
| 123 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.02297532 |
| 124 | Metabolic pathways_Homo sapiens_hsa01100 | 0.00563833 |
| 125 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.00464600 |
| 126 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | -0.0185849 |
| 127 | Butanoate metabolism_Homo sapiens_hsa00650 | -0.0108483 |
| 128 | Phenylalanine metabolism_Homo sapiens_hsa00360 | -0.0093243 |

